icad Inc (ICAD)
1.44
0.00 (0.00%)
USD |
NASDAQ |
May 01, 16:00
1.44
0.00 (0.00%)
After-Hours: 18:08
icad Enterprise Value: 16.28M for April 30, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 30, 2024 | 16.28M |
| April 29, 2024 | 17.33M |
| April 26, 2024 | 17.07M |
| April 25, 2024 | 17.33M |
| April 24, 2024 | 19.44M |
| April 23, 2024 | 19.44M |
| April 22, 2024 | 18.39M |
| April 19, 2024 | 18.92M |
| April 18, 2024 | 20.23M |
| April 17, 2024 | 19.44M |
| April 16, 2024 | 20.50M |
| April 15, 2024 | 21.29M |
| April 12, 2024 | 22.87M |
| April 11, 2024 | 23.13M |
| April 10, 2024 | 23.40M |
| April 09, 2024 | 25.77M |
| April 08, 2024 | 21.29M |
| April 05, 2024 | 20.76M |
| April 04, 2024 | 21.29M |
| April 03, 2024 | 28.40M |
| April 02, 2024 | 20.50M |
| April 01, 2024 | 18.39M |
| March 28, 2024 | 20.76M |
| March 27, 2024 | 20.50M |
| March 26, 2024 | 19.84M |
| Date | Value |
|---|---|
| March 25, 2024 | 19.18M |
| March 22, 2024 | 20.50M |
| March 21, 2024 | 20.50M |
| March 20, 2024 | 19.18M |
| March 19, 2024 | 18.12M |
| March 18, 2024 | 17.60M |
| March 15, 2024 | 20.23M |
| March 14, 2024 | 20.76M |
| March 13, 2024 | 25.77M |
| March 12, 2024 | 23.92M |
| March 11, 2024 | 24.58M |
| March 08, 2024 | 28.14M |
| March 07, 2024 | 28.40M |
| March 06, 2024 | 29.98M |
| March 05, 2024 | 29.98M |
| March 04, 2024 | 38.02M |
| March 01, 2024 | 27.61M |
| February 29, 2024 | 25.50M |
| February 28, 2024 | 24.71M |
| February 27, 2024 | 19.71M |
| February 26, 2024 | 19.44M |
| February 23, 2024 | 15.49M |
| February 22, 2024 | 14.17M |
| February 21, 2024 | 14.70M |
| February 20, 2024 | 16.41M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
9.000M
Minimum
Mar 28 2023
489.67M
Maximum
Mar 31 2021
142.07M
Average
118.82M
Median
Jan 14 2022
Enterprise Value Benchmarks
| ClearPoint Neuro Inc | 133.83M |
| Perspective Therapeutics Inc | 978.51M |
| Xtant Medical Holdings Inc | 132.57M |
| Asensus Surgical Inc | 46.00M |
| Catheter Precision Inc | 0.776M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 2.055M |
| Revenue (Quarterly) | 4.74M |
| Total Expenses (Quarterly) | 5.457M |
| EPS Diluted (Quarterly) | 0.05 |
| Gross Profit Margin (Quarterly) | 91.18% |
| Profit Margin (Quarterly) | 43.35% |
| Earnings Yield | -15.28% |
| Normalized Earnings Yield | -19.44 |